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a b s t r a c t
Aristolochia ringens Vahl. (Aristolochiaceae (AR); 馬兜鈴 mǎ dou líng) is used traditionally in Nigeria for
the management of various disorders including oedema. Preliminary investigation revealed its modu-
latory effect on the cardiovascular system. This study was aimed at investigating the effect of the aqueous
root extract of A. ringens (AR) on haemodynamic parameters of spontaneously hypertensive rats (SHRs).
The effect of oral subacute (21 days) and intravenous acute exposure of SHRs to the extract were assessed
using tail cuff and carotid artery canulation methods respectively. In the latter, the effect of chloroform,
butanol and aqueous fractions of AR were also evaluated. The extract signiﬁcantly reduced systolic and
diastolic blood pressures in SHRs, with peak reductions of 20.3% and 26.7% respectively at 50 mg/kg by
the 21st day of oral subacute exposure. Upon intravenous exposure, AR (50 mg/kg) reduced systolic and
diastolic blood pressure by as much as 53.4 ± 2.2 and 49.2 ± 2.8 mmHg respectively. A dose-dependent
reduction in heart rate, signiﬁcant at 25 and 50 mg/kg was also observed. Hexamethonium (20 mg/kg)
and atropine (1 mg/kg) inhibited the extract's reduction of systolic blood pressure, diastolic blood
pressure and heart rate signiﬁcantly. The extract's butanol fraction produced the greatest systolic and
diastolic blood pressures reduction of 67.0 ± 3.8 and 68.4 mmHg respectively at 25 mg/kg and heart rate
reduction of 40 ± 7 beats per minute at 50 mg/kg. HPLC analysis revealed the presence of 4-
hydroxybenzoic acid and quercetin in AR. The extract's alterations of haemodynamic parameters in
this study show that it has hypotensive effect on spontaneously hypertensive rats.
© 2017 Center for Food and Biomolecules, National Taiwan University. Production and hosting by Elsevier
Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
1. Introduction
Hypertension, a condition in which the arteries have persis-
tently elevated blood pressure, is a prevalent risk factor for car-
diovascular diseases; affecting over 1 billion people worldwide.1 A
continuous relationship between blood pressure and
cardiovascular risks, renal disease and mortality has been reported.
This relationship particularly holds more for systolic than for dia-
stolic blood pressure.2 There is a doubling of the risk of stroke and
ischaemic heart disease mortality for every 20/10 mmHg increase
in blood pressure over the level 115/75 mmHg.3 In 2000, it was
estimated that 25% of the world's adult population were hyper-
tensive, and predicted that this would rise to 29% by 2025. By the
age of 60, more than one-half of adults in most regions of the world
will be hypertensive.3
Two forms of hypertension, namely primary and secondary
hypertension, have been described. The more common form is
primary hypertension also known as essential or idiopathic hy-
pertension. It accounts for 90e95% of all cases of hypertension. In
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spite of the immense progress in understanding of its pathophys-
iology and availability of various efﬁcacious management ap-
proaches, essential hypertension is a major risk factor for
cardiovascular disorders. Hypertension increases the risk of car-
diovascular diseases for millions of people worldwide. In the past
decade, age-related incidence of stroke, renal and heart failure has
reportedly risen. This observation is partly due to inadequate
control of blood pressure in the hypertensive population.4 It has
been reported that less than 25% of treated hypertensive patients
achieve target blood pressure.5 Studies have demonstrated that
although antihypertensives are very beneﬁcial therapeutically, they
are associated with certain limitations, the outcome of which
however is inﬂuenced by risk factors such as patient's age and pre-
existing co-morbid conditions.6 The need for more effective and
better tolerated antihypertensive therapies cannot be over-
emphasized. Medicinal plants are very important sources of po-
tential novel antihypertensives. Indeed, the antihypertensive ef-
fects of some of these plants have been validated and others
disproved.
Aristolochia ringens is one of the over 500 species of the Aris-
tolochiaceae family of medicinal plants. Historically, Aristolochia
species of plants have long been in use in traditional medicine
practice. They have also been very much featured in numerous
chemical and pharmacological research.7 However, there have been
reports of the potential toxicity of plants of the Aristolochiaceae
family due to the presence of aristolochic acids, which has resulted
in the ban of products containing Aristolochia species or aristolochic
acids in several countries of the world. Despite this fact, studies in
some quarters have shown the immense potential beneﬁts of
Aristolochia species owing to the presence of other phytochemicals
present in them. Kuo et al.8 reported the neuroprotective, anti-
spasmodic, antiaddictive and antimycobacterial effects of other
Aristolochia plants' phytochemicals (other than aristolochic acids).
Some other classes of phytochemicals isolated from the species
include lignans, terpenoids, steroids, coumarins and ﬂavonoids
among others.
A. ringens is a commonly used species in Nigeria. It is known as
“Akogun” (Yoruba language) in Southwestern Nigeria. It is used for
themanagement of oedema, worm infestation, gastrointestinal and
inﬂammatory disorders as well as several other ailments.9 Studies
have also revealed its antidiarrhoeal,10 anti-inﬂammatory11 and
anticancer activities.12 Although A. ringens contains aristolochic
acid II, sesquiterpenes and monoterpenes have also been isolated
from the plant.13 Wu et al.14 reported the presence of speciﬁc
monoterpenoids (e.g. limonene) and sesquiterpenoids (e.g. car-
yophyllanes). Its composition of magnesium, phosphorus, calcium,
iron, zinc, copper and other elements have also been reported.15
Clearly, A. ringens contains other useful phytochemicals that could
be harnessed as lead compounds for drug development in the
management of various disorders including primary hypertension.
A pilot study carried out in our laboratory revealed that it reduces
inotropic and chronotropic effects of an isolated rabbit heart and
also induces vasomodulatory activity on isolated rat aortic ring.
This study was aimed at investigating some effects of the aqueous
root extract of A. ringens (AR) on haemodynamic parameters of
essential hypertension as modelled by spontaneously hypertensive
rats.
2. Materials and methods
2.1. Plant collection and identiﬁcation
The root of A. ringens collected from a local market in Mushin,
Lagos, Nigeria was identiﬁed and authenticated by Mr. T.K. Odewo,
a taxonomist of the Department of Botany and Microbiology, Uni-
versity of Lagos, Nigeria where a herbarium specimen was depos-
ited with voucher number LUH 4061.
2.2. Plant extraction
Air dried root (100 g) was macerated in 1000 ml of distilled
water and placed in a refrigerator at 4 C for 5 days. It was then
ﬁltered using cotton wool and ﬁlter paper, and the ﬁltrate dried in
an oven (Gallenhamp®, England) at 40 C. The percentage yield of
the aqueous root extract of A. ringens (AR) obtained was 4.9% (w/w).
For some of the experiments, the extract was further subjected to
liquid-liquid partitioning to obtain chloroform, butanol and
aqueous fractions of the extract.
2.3. Experimental animals
Adult male spontaneously hypertensive rats (180e320 g) were
obtained from the Animal Research Unit and Service Centre
(ARASC) of Universiti SainsMalaysia, Penang, Malaysia. The animals
were allowed to acclimatize for a week, housed under standard
environmental conditions in standard plastic cages and maintained
under a 12 h light and 12 h dark cycle. They were fed with normal
commercial rat chow (Gold Coin FeedMills, Sdn Bhd, Malaysia) and
water ad libitum. Animal handling and all procedures on animals
were carried out in accordance with the guidelines of the Animal
Care and Use Committee of the Universiti Sains Malaysia.
2.4. Chemicals
The chemicals used in this study include dimethyl sulfoxide,
acetone, petroleum ether, butanol, chloroform, hexamethonium,
atropine, Folin-Ciocalteu reagent, sodium bicarbonate, gallic acid,
quercetin, 4 hydroxybenzoic acid, 2,2-diphenyl-1-picrylhydrazyl,
Acetic acid (Sigma Aldrich, Malaysia), distilled water (Cardiovas-
cular and Renal Units Laboratory, USM, Malaysia).
2.5. Effect of chronic administration of AR on blood pressure and
heart rate
Four groups of 5 spontaneously hypertensive rats (SHRs) each
were orally administered AR (25 and 50mg/kg), enalapril (3 mg/kg)
and vehicle (distilled water at 5 ml/kg) for 21 days. Blood pressure
and heart rate were measured using the tail cuff method with
CODA® non-invasive blood pressure monitor (Kent Scientiﬁc Co-
operation, USA) on days 0, 7, 14 and 21. On these days, 24-hour
urine samples were also obtained by placing each rat singly in
metabolic cages for 24 h.16 The volume of urine collected was
measured using measuring cylinder; and the urine Naþ and Kþ
concentrations were determined using a ﬂame photometer (Jen-
way, Uk).
2.6. Effect of acute exposure to AR on blood pressure and heart rate
This was done using a modiﬁcation of the methods described by
Shah and Gilani.17 Spontaneously hypertensive rats fasted for 12 h,
were anaesthetized with pentobarbitone (60 mg/kg, i.p.). Imme-
diately following the anaesthesia, tracheotomy was performed
using an endotracheal cannula (PP 240, Portex Ltd, Kent, UK) to
maintain a free ﬂow of air through the trachea. The left jugular vein
was then catheterized using PP 50 tubing (Portex Ltd, Kent, UK) to
allow the infusion of supplementary anaesthesia, AR and its vehicle
and fractions. For the measurement of blood pressure and heart
rate, the right carotid artery was cannulated with PP 50 tubing
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(Portex Ltd Kent, UK), which was connected to a pressure trans-
ducer (P23 ID Gould, Statham Instruments, UK) linked to a data
acquisition system (PowerLab®, ADInstruments, Sydney, Australia)
through a Quad Amp (ADInstruments, Australia) using chart
(V.6.1.1) software. The temperature of the animal wasmaintained at
37 C using an overhead lamp. Animals were allowed to equilibrate
for at least 30 min before the administration of any drug. Arterial
pressure was allowed to return to the resting level between the
administrations. Prior to the administration of AR, its vehicle frac-
tions, they were passed through a 0.45 mm pore syringe ﬁlter. The
haemodynamic parameters were noted before and after the
administration of AR (6.25e50 mg/kg) and corresponding equal
volumes of the vehicle. The effect of the chloroform, butanol and
aqueous fractions of AR were also determined. In some of the ex-
periments, the effect of the extract at 50 mg/kg was also noted in
the presence of intravenously administered atropine (1 mg/kg) or
hexamethonium (20 mg/kg).
2.7. Determination of phenolics in AR and fractions
For the determination of the phenolic contents of AR and its
petroleum ether, chloroform, butanol and aqueous fractions, the
Folin-Ciocalteu method as described by Barros et al.18 was applied
but modiﬁed for use with microplates. Twenty three (23) ml of AR
and fractions (5 mg/ml) were added to 23 ml of Folin-Ciocalteu
reagent respectively. After 3 min, saturated Na2CO3 was added to
the mixture, which was made up to 130 ml with distilled water. The
reaction was kept in the dark for 90 min, after which the absor-
bance was read using a microplate reader at 725 nm. Gallic acid
(0.0005e0.5 mg/ml) was used to obtain standard calibration curve.
Estimation of the phenolic contents was carried out in triplicate
and results were expressed as gallic acid equivalents.
2.8. Diphenyl-1-picryl-hydrazyl (DPPH) assay
To determine the radical scavenging activity (RSA) of AR and its
fractions against 2,2-diphenyl-1-picrylhydrazyl (DPPH), 0.01 ml of
AR (0.0005e0.5 mg/ml), its fractions (0.0005e0.5 mg/ml) or blank
was added to 0.29 ml of DPPH 104 M respectively and the absor-
bance (A) determined at 517 nm after 30min incubation in the dark
at room temperature. Radical scavenging activity (RSA) was
calculated in percent using the following formulae:
%RSA ¼

ADPPH  Аsample
.
ADPPH  Аblank

 100:
2.9. Identiﬁcation and quantiﬁcation of phenolics in AR using HPLC
HPLC analysis for phenolic contents of AR was conducted using
Shimadzu HPLC apparatus coupled with a ﬂourimetric detector.
The phenolic compounds were detected at excitation and emis-
sion wavelengths, lex/lem ¼ 226/420 nm. Solvent gradients were
formed using the dual pump system by varying the proportion of
solvent A [watereacetic acid (97:3)] to solvent B (methanol). The
solvent gradient elution programme used was as follows (total
run time of 60 min); 100% solvent A/0% solvent B at 0 min; 90% A/
10% B at 10 min, 30% A/70% B at 40 min, 100% A/0% B at
44e50 min. Under these conditions, 20 ml of sample (AR 20 mg/
ml) or standard phenolics (25e100 mg/ml) were injected. All
sample analyses were assayed for in triplicate. The phenolic
contents of AR were detected by matching the retention time and
their spectral characteristics against those of standards. Quanti-
tation was made according to the calibration curves of respective
standard compounds.
2.10. Statistical analyses
Results obtained were expressed as mean ± SEM. Experimental
data obtained from the studies were analyzed using one way
analysis of variance (ANOVA) followed by Turkey's multiple com-
parison test or two way ANOVA followed by Bonferroni's post hoc
test using Graph Pad Prism 5 statistical package. Results were
considered signiﬁcant at p < 0.05.
3. Results
3.1. Effect of 21 days treatment of AR on blood pressure and heart
rate of SHRs
AR (25e50 mg/kg; p.o.) administered for 21 days signiﬁcantly
reduced systolic and diastolic blood pressure in SHRs. The hypo-
tensive effect of the extract was evident by the 7th day of admin-
istration and continued through the 14th to the 21st day of
exposure. The peak reduction of systolic and diastolic blood pres-
sure by AR at 50 mg/kg was observed by the 21st day. This reduc-
tion of 165.1 ± 6.3/124.0 ± 3.3 mmHg (blood pressure by day 0) to
131.0 ± 1.8/91.0 ± 3.7 mmHg was comparable to the reduction of
157.0 ± 7.2/118.0 ± 5.3 mmHg to 126.0 ± 8.9/86.0 ± 6.7 mmHg
produced by enalapril (3 mg/kg). No signiﬁcant alteration in heart
rate by ARwas observed except on the 14th day of the study when a
reduction from 401 ± 15 to 337 ± 07 beats per minute was observed
in SHRs receiving AR (50 mg/kg) as depicted in Table 1.
Table 1
Effect of 21 days treatment of AR on blood pressure and heart rate of SHRs.
Group Dose (mg/kg) Day 0 Day 7 Day 14 Day 21
Systolic blood pressure (mmHg)
Control 10 (ml/kg) 161.2 ± 2.9 168.4 ± 0.8 168.7 ± 4.1 157.6 ± 4.2
AR 25 165.6 ± 3.0 149.5 ± 3.1 145.9 ± 2.6a 137.0 ± 3.9
AR 50 165.1 ± 6.3 148.5 ± 4.6a 140.0 ± 7.3c 131.6 ± 1.8c
Enalapril 3 157.0 ± 7.2 133.6 ± 3.9d 135.0 ± 4.4d 137.1 ± 8.9a
Diastolic blood pressure (mmHg)
Control 10 (ml/kg) 117.9 ± 1.9 125.8 ± 1.7 128.7 ± 1.0 115.2 ± 3.5
AR 25 124.0 ± 3.5 108.0 ± 1.0b 105.3 ± 2.6c 98.1 ± 3.2a
AR 50 124.2 ± 3.3 104.2 ± 1.9c 106.6 ± 4.0c 91.0 ± 3.7d
Enalapril 3 118.1 ± 5.3 94.3 ± 4.7d 99.3 ± 3.5d 86.1 ± 6.7d
Heart rate (beats per minute)
Control 10 (ml/kg) 404 ± 28 367 ± 6 402 ± 24 434 ± 34
AR 25 382 ± 10 358 ± 11 358 ± 7 374 ± 10
AR 50 401 ± 15 391 ± 9 337± 7a 372 ± 7
Enalapril 3 410 ± 20 382 ± 17 397 ± 17 425 ± 27
Vaules are mean ± SEM. ap< 0.05, bp < 0.01, cp < 0.001, dp < 0.0001 vs. control (Two way analysis of variance followed by Bonferoni's post hoc test). BPM-beats per minute.
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3.2. Effect of AR on urine volume and electrolytes
In the assay to determine the effect of AR on urine volume and
electrolytes, it was observed that AR produced no signiﬁcant
change in 24 h urine output of SHRs on days 7, 14 and 21 of AR
exposure. No signiﬁcant changes in sodium and potassium con-
centrations of these urine samples were observed (Table 2).
3.3. Effect of acute administration of AR on blood pressure and
heart rate of SHRs
In the experiment to determine the effect of acute intravenous
exposure of SHRs to AR (6.25e50 mg/kg), signiﬁcant dose-
dependent reductions in systolic and diastolic blood pressures
were observed in SHRs. The greatest effect was observed at 50 mg/
kg with reductions of 53.4 ± 2.2 and 49.2 ± 2.8 mmHg in systolic
and diastolic blood pressures respectively. A dose-dependent
reduction in heart rate, signiﬁcant at 25 and 50 mg/kg was also
observed with intravenous exposure of SHRs to AR. The extract
(50mg/kg) reduced heart rate by 14 ± 2.3 beats per minutes (Fig. 1).
The reduction of blood pressure and heart rate by AR (50 mg/kg)
was signiﬁcantly inhibited by hexamethonium (20 mg/kg) and
atropine (1 mg/kg). Hexamethonium inhibited AR-induced reduc-
tion in systolic blood pressure, diastolic blood pressure and heart
rate by 61.0%, 51.6% and 69.6% respectively. Atropine also inhibited
AR-induced reduction of these parameters by 66.5%, 61.9% and
73.9% respectively (Fig. 2).
In the aspect of the study to evaluate the effect of intravenously
administered AR and its fractions, butanol and aqueous fractions
signiﬁcantly reduced blood pressure and heart rate of SHRs. The
butanol fraction produced the greatest reduction, with systolic and
diastolic blood pressure reductions by 67.0 ± 3.8 and 68.4 mmHg
respectively at 25 mg/kg and heart rate reduction by 40 ± 7 beats
per minute at 50 mg/kg. The reduction of these haemodynamic
parameters observed with the aqueous fraction was comparable to
that of the extract. The chloroform fraction on the other hand,
produced no signiﬁcant effect on these parameters (Fig. 3).
3.4. Quantitative determination of total tannins, ﬂavonoids and
phenolics in AR and its fractions
In the study to determine the concentration of these compo-
nents in AR and its fractions, it was observed that the aqueous root
extract of AR contains 26.00 ± 0.00 mg/g tannic acid equivalent,
48.00 ± 0.01 mg/g quercetin equivalent and 222.00 ± 0.00 mg/g
gallic acid equivalent of tannins, ﬂavonoids and phenolics respec-
tively. The chloroform fraction of AR had the highest content of
tannins (130.00 ± 0.03 mg/g tannic acid equivalent), while the
butanol fraction contained the most ﬂavonoids (80.00 ± 0.01 mg/g
quercetin equivalent) and phenolics (316.00 ± 0.00 mg/g gallic acid
equivalent) as shown in Table 3.
3.5. Diphenyl-1-picryl-hydrazyl (DPPH) assay
In this study, AR and its fractions (0.0005e0.5mg/ml) scavenged
free radicals. AR produced 65% inhibition of free radical generation
at 0.5 mg/ml. Of the fractions of AR tested, the butanol fraction
Table 2
Effect of AR on urine volume and electrolytes of SHRs.
Group Dose (mg/kg) Day 0 Day 7 Day 14 Day 21
Urine volume (ml)
Control 10 (ml/kg) 5.88 ± 1.25 8.36 ± 1.68 11.10 ± 4.50 7.12 ± 1.17
AR 25 6.10 ± 0.73 7.20 ± 2.03 8.10 ± 3.04 7.90 ± 2.06
AR 50 5.40 ± 0.80 6.80 ± 1.00 6.70 ± 1.64 5.90 ± 0.60
Urine sodium (nM/l)
Control (ml/kg) 10 165.50 ± 30.30 129.30 ± 0.70 128.50 ± 13.20 130.80 ± 18.40
AR 25 165.00 ± 40.90 137.80 ± 20.40 134.60 ± 14.30 155.00 ± 5.40
AR 50 155.50 ± 12.60 138.80 ± 07.10 131.50 ± 19.80 121.00 ± 15.10
Urine potassium (mM/l)
Control (ml/kg) 10 489.40 ± 24.00 269.30 ± 25.50 337.30 ± 122.20 395.00 ± 33.50
AR 25 393.30 ± 29.40 250.00 ± 57.40 282.30 ± 22.30 318.80 ± 25.10
AR 50 387.70 ± 59.40 331.00 ± 35.40 249.30 ± 62.10 276.80 ± 31.10
Vaules are mean ± SEM. P < 0.05 (Two way analysis of variance followed by Bonferoni's post hoc test).
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Fig. 1. Effect of acute administration of AR on systolic blood pressure (A), diastolic
blood pressure (B) and heart rate (C). Bars represent mean ± SEM. ap< 0.05, bp < 0.01,
cp < 0.001 vs. control (Two way analysis of variance followed by Bonferroni post test).
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showed the greatest inhibition (77% inhibition) at 0.5 mg/ml; this
action was greater than that of the reference ﬂavonoid, quercetin
(67% inhibition), at the same concentration (Fig. 4).
3.6. Identiﬁcation and quantiﬁcation of phenolics in AR using HPLC
In the HPLC analysis to identify and quantify speciﬁc phenolics
in AR, 4-hydroxybenzoic acid, caffeic acid, catechin hydrate,
coumaric acid, chlorogenic acid, ferulic acid, quercetin and sinnapic
acid were assayed for. Of these, 4-hydroxybenzoic acid and quer-
cetin were detected and found to be 0.469 ± 0.09 mg and
2.290 ± 0.33 mg 4-hydroxybenzoic acid and quercetin equivalents
per g of AR respectively. Figs. 5 and 6 show the chromatograms of
AR aligned with those of 4-hydroxybenzoic acid and quercetin
respectively.
4. Discussion
Daily administration of AR via the oral route for 21 days, caused
signiﬁcant reduction of systolic and diastolic blood pressure in
conscious spontaneously hypertensive rats. This effect of the
extract, which was observable by the 7th day of exposure was
found to be comparable to the hypotensive effect of enalapril.
Fig. 2. Effect of AR on systolic blood pressure (A), diastolic blood pressure (B) and heart
rate (C) in the absence and presence of 20 mg/kg hexamethonium (Hex) and 1 mg/kg
atropine (Atr). Bars represent mean ± SEM. bp < 0.01, cp < 0.001 vs. control (One way
analysis of variance followed by Tukey's multiple comparison test).
Fig. 3. The effect of AR and fractions on systolic blood pressure (A), diastolic blood
pressure (B) and heart rate (C). Lines represent mean ± S.E.M. bp < 0.01, cp < 0.001 vs.
control; bp< 0.01, gp< 0.001 vs. AR (Two way ANOVA followed by Tukey's multiple
comparison test). AR-aqueous root extract of A. ringens, AqAR-aqueous fraction of AR,
ButAR-butanol fraction of AR, CfAR-chloroform fraction of AR.
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Change in heart rate was only observed by the 14th day of exposure
to AR at 50 mg/kg. Such nearly insigniﬁcant effect on cardiac rate
has been reported previously of potentially hypotensive medicinal
plants such as Lepidium sativum and Fraxinus excelsior.19 Diuresis is
one of the approaches employed in the management of hyperten-
sion. In the aspect of the study to investigate the effect of AR on
urine volume and electrolyte, it was observed that AR showed no
diuretic effect; as urine volume, sodium and potassium were un-
affected throughout the chronic exposure study period. This shows
that the blood pressure lowering action of AR is not mediated via
diuretic mechanism.
The results of the present study also showed that AR, on intra-
venous administration, induces a dose-dependent acute hypoten-
sive effect on anaesthetized SHRs; reducing signiﬁcantly, systolic
and diastolic blood pressure as well as heart rate, the reduction of
which was signiﬁcant at 25 and 50 mg/kg. Consistent with the
results in the 21 days oral exposure, AR produced greater re-
ductions in the systolic blood pressure compared to diastolic blood
pressure. Compared to oral administration, intravenous adminis-
tration resulted in greater reduction of blood pressure, which
shows that oral administration of AR may reduce the pharmaco-
logical effect of the extract, perhaps due to hepatic metabolism of
the orally administered extract, thus reducing its bioavailability.
To examine the possible mechanism involved in this response,
the extract's effect on the haemodynamic parameters studied were
determined in the presence of atropine (a non-selective muscarinic
antagonist) and hexamethonium (an autonomic ganglion blocker).
Pre-treatment of rats with hexamethonium and atropine signiﬁ-
cantly inhibited the hypotensive effect of the plant extract;
reducing signiﬁcantly, the extent of systolic and diastolic blood
pressure reductions as well as heart rate reduction. This suggests
that the extract's mechanism of hypotensive action may involve
interferences with transmissions at the autonomic ganglia and
muscarinic receptors.
In the study to investigate the action of the fractions of AR; the
effect of its chloroform, butanol and aqueous fractions were
compared to that of its crude form. Its butanol fractionwas found to
be themost active. The effects of the butanol fraction of AR on blood
pressure and heart rate were signiﬁcantly greater than those of AR,
while the effects of its aqueous fraction were comparable to that of
AR. The effect observed with butanol fraction may be due to its
relatively high content of phenolics and ﬂavonoids; as it was shown
to possess the highest concentration of these components in the
study. Compared to AR, the chloroform fraction produced no sig-
niﬁcant effect on blood pressure and heart rate, suggesting that it
does not contain principles with activity in this regard. In fact, the
chloroform fraction demonstrated a signiﬁcant reversal of the ex-
tract's effects on systolic and diastolic blood pressure as well as
heart rate of the rats.
Tannins, ﬂavonoids and other phenolics were found to be pre-
sent in both the crude extract and fractions of AR using quantitative
methods of analyses. From this aspect of the study, AR was found to
contain as much as 26 mg tannic acid equivalent per g of AR. Its
petroleum ether, chloroform, butanol, and aqueous fractions were
also found to contain tannic acid ranging from 20 to 130 mg tannic
acid equivalent per g of AR. This appreciable concentration of total
tannins in AR and its fractions reveal that indeed some of the ac-
tions of AR can be accounted for by its tannin content. Phenolics
and ﬂavonoids have been reported to possess many beneﬁcial ef-
fects including antihypertensive actions.20 The antihypertensive
effect of tannins have been reported by Turgut et al.21
Phenolics are reported to be highly ubiquitous in nature. The
total ﬂavonoids and phenolics assay showed that AR and its frac-
tions contain very appreciable concentrations. Phenolics, which
include ﬂavonoids and tannins are known to be highly effective in
free radical scavenging and are therefore used to manage ailments
in which oxidative stress are implicated.22 The presence of these
phytochemicals in A. ringens and its fractions is therefore highly
signiﬁcant in this study. Of the fractions tested, the butanol fraction
of AR, was shown to possess the highest concentration of ﬂavonoids
and phenolics.
DPPH assay is an antioxidant test procedure that employs 1,1-
diphenyl-2-picrylhydrazyl radical (DPPH), which has an unpaired
electron and exhibits a stable violet colour in methanol solution. It
is commonly used for evaluation of the free radical scavenging
activity of antioxidants.23 The assay is based on the reduction of
DPPH in the presence of a hydrogen-donating antioxidant, resulting
in the formation of the non-radical form, (DPPH-H).24,25 In this
assay, the butanol fraction of AR, which showed the highest con-
centration of phenolics and ﬂavonoids, produced the most anti-
oxidant activity.
More speciﬁcally, HPLC analysis revealed the presence of
phenolic, 4-hydroxybenzoic acid, and ﬂavonoid, quercetin, in AR,
the medicinal properties of which can be largely attributable to the
inhibition of free radical activity. Indeed, the antioxidant activity of
4-hydroxybenzoic acid26 and quercetin27 have been reported.
Duarte et al.28 reported the antihypertensive effect of quercetin in
spontaneously hypertensive rats. It is therefore clear that the
presence of these components in AR contribute to the effects
observed in this study.
Table 3
Quantitative analysis of tannin, ﬂavonoid and phenolic contents of AR and its fractions.
AR/fraction Tannins (mg tannic acid equivalent
per g of dried extract)
Flavonoids (mg quercetin equivalent
per g of dried extract)
Phenolics (mg gallic acid equivalent
per g of dried extract)
AR 26.00 ± 0.00 48.00 ± 0.01 222.00 ± 0.00
PeAR 26.00 ± 0.02 34.00 ± 0.01 100.00 ± 0.03
CfAR 130.00 ± 0.03 50.00 ± 0.02 198.00 ± 0.04
ButAR 20.00 ± 0.01 80.00 ± 0.01 316.00 ± 0.00
AqAR 26.00 ± 0.00 34.00 ± 0.01 174.00 ± 0.05
Values are mean ± S.E.M. AR-aqueous root extract of A. ringens, PeAR-petroleum ether fraction of AR, CfAR-chloroform fraction of AR, ButAR-butanol fraction of AR, AqAR-
aqueous fraction of AR.
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Fig. 4. Effect of AR and its fractions in the 2,2-Diphenyl-1-picryl-hydrazyl (DPPH)
assay. Bars represent mean ± S.E.M. PeAR-petroleum ether fraction of AR, CfAR-
chloroform fraction of AR, ButAR-butanol fraction of AR, AqAR-aqueous fraction of AR.
F.R. Aigbe et al. / Journal of Traditional and Complementary Medicine xxx (2017) 1e96
Please cite this article in press as: Aigbe FR, et al., Alterations of haemodynamic parameters in spontaneously hypertensive rats by Aristolochia
ringens Vahl. (Aristolochiaceae), Journal of Traditional and Complementary Medicine (2017), http://dx.doi.org/10.1016/j.jtcme.2017.02.006
Fig. 5. HPLC chromatogram of reference standard, 4-hydroxybenzoic acid (A) and the aqueous root extract of A. ringens (B).
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Fig. 6. HPLC chromatogram of reference standard, quercetin (A) and the aqueous root extract of A. ringens (B).
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5. Conclusion
It can be concluded that the extract possessed hypotensive ac-
tivity in spontaneously hypertensive rats and induced bradycardia
in them. These effects were shown to be mediated via its interac-
tion at the autonomic ganglia and muscarinic receptors. The study
also showed that diuresis is not involved in the extract's hypoten-
sive effect. Its butanol fraction was the most effective against hy-
pertension in spontaneously hypertensive rat. Phytochemical
studies showed that the extract contained relatively high concen-
trations of various phenolics, of which 4-hydroxybenzoic acid and
quercetin were identiﬁed. These ﬁndings reveal that the aqueous
extract of A. ringens contains principles that could be harnessed for
their therapeutic beneﬁts. Further activity guided fractionation
studies on the butanol fraction of AR geared towards character-
ization of the active principle(s) and elucidation of the mecha-
nism(s) of action of such constituents are underway.
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